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Abstract
Shoulder instability is a common shoulder injury, and patients present with plastic deformation of the glenohumeral
capsule. Gene expression analysis may be a useful tool for increasing the general understanding of capsule deformation,
and reverse-transcription quantitative polymerase chain reaction (RT-qPCR) has become an effective method for such
studies. Although RT-qPCR is highly sensitive and specific, it requires the use of suitable reference genes for data
normalization to guarantee meaningful and reproducible results. In the present study, we evaluated the suitability of a set
of reference genes using samples from the glenohumeral capsules of individuals with and without shoulder instability. We
analyzed the expression of six commonly used reference genes (ACTB, B2M, GAPDH, HPRT1, TBP and TFRC) in the antero-
inferior, antero-superior and posterior portions of the glenohumeral capsules of cases and controls. The stability of the
candidate reference gene expression was determined using four software packages: NormFinder, geNorm, BestKeeper and
DataAssist. Overall, HPRT1 was the best single reference gene, and HPRT1 and B2M composed the best pair of reference
genes from different analysis groups, including simultaneous analysis of all tissue samples. GenEx software was used to
identify the optimal number of reference genes to be used for normalization and demonstrated that the accumulated
standard deviation resulting from the use of 2 reference genes was similar to that resulting from the use of 3 or more
reference genes. To identify the optimal combination of reference genes, we evaluated the expression of COL1A1. Although
the use of different reference gene combinations yielded variable normalized quantities, the relative quantities within
sample groups were similar and confirmed that no obvious differences were observed when using 2, 3 or 4 reference genes.
Consequently, the use of 2 stable reference genes for normalization, especially HPRT1 and B2M, is a reliable method for
evaluating gene expression by RT-qPCR.
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Introduction
Shoulder dislocation occurs in 1 to 2% of the population [1],
and traumatic injuries account for 95% of shoulder dislocation
episodes [2]. These shoulder injuries are frequently observed in
young athletes that are involved in competitive sports [3], and
shoulder instability (SI) is often observed after the initial episode of
shoulder dislocation, with a recurrence rate of up to 100% in
young athletes [4,5].
After episodes of shoulder dislocation, SI patients present plastic
deformation of the glenohumeral capsule [6,7]. Although the
antero-inferior (AI) region of the capsule is the most frequently
injured site [7,8], previous macroscopic analysis of the collagen
fiber bundle architecture in the AI region of the glenohumeral
capsule revealed that a system of bundles spirally crossing one
another permits the entire capsule to resist tensile and shear loads
[9]. As a result, there is a reciprocal load-sharing relationship
within the capsule whereby tensile load in either the anterior or
superior structures is concomitant with laxity in the posterior (P) or
inferior portion, respectively [7], suggesting that different portions
of the capsule may be modified in traumatic anterior SI cases.
Currently, little is known about capsule biology, especially in
patients with SI. An improved understanding of the underlying
biology will be important for guiding patient management and
development of new therapeutic options that will be complemen-
tary to surgery. Our group recently began investigating alterations
in gene expression in SI, as gene expression analysis has previously
been used to increase understanding of the molecular events
involved in other traumatic sport injuries such as ligament [10,11]
and tendon injuries (for a review, see [12]).
As a result of its accuracy, sensitivity and capacity for high
throughput analysis, reverse-transcription quantitative polymerase
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chain reaction (RT-qPCR) is currently considered to be the gold
standard technique for evaluation of gene expression [13];
furthermore, this technique is commonly used to validate data
obtained by other methods [14].
To obtain reliable data using RT-qPCR, gene expression levels
must be normalized using internal controls within each sample
[15]. The use of one or more reference genes can correct biases
caused by variations in the complementary DNA (cDNA) input or
the efficiency of reverse transcription or amplification. Ideally,
reference genes should be stably expressed or at least vary only
slightly in expression in all tissues or cells under the conditions of
the experiment [16].
Although several genes are commonly used as controls (e.g.,
GAPDH and ACTB), they can also be regulated and expressed at
varying levels [17]. Because the quality of data from gene
expression analyses is affected by the quality of reference genes
used, it is recommended that reference gene expression stability be
validated for each target tissue and disease [18,19].
The suitability of reference genes has been evaluated in some
human musculoskeletal disease such as osteoarthritic articular
cartilage (hip and knee) [20], human lumbar vertebral endplate
with modic changes [21] and skeletal muscle with chronic
degenerative changes [22]. However, to our knowledge no
previous studies have identified the best individual or set of
reference genes for gene expression analysis from samples of
shoulder capsules.
In this study, we assessed the suitability of six reference genes
frequently used in the literature (ACTB, B2M, GAPDH, HPRT1,
TBP and TFRC) using samples from 3 sites within the
glenohumeral capsule [AI, antero-superior (AS) and P portions]
of SI patients and control individuals by analyzing gene stability
using 4 freely available software packages.
Materials and Methods
Patients
We tested tissue samples from 13 patients with traumatic
anterior SI from Sa˜o Paulo Hospital of the Federal University of
Sa˜o Paulo (UNIFESP), Brazil. All of the patients were treated with
shoulder immobilization for a minimum of 2 weeks following the
first episode of shoulder dislocation and underwent arthroscopic
surgical treatment for SI.
Additionally, 5 patients who underwent arthroscopically assisted
treatment for acromioclavicular dislocation were included in this
study as a control group. These patients did not present with any
history of SI or signs of SI injury under anesthesia; furthermore,
we did not find any radiological indications of glenohumeral
capsule alterations. All control patients were physically active.
Table 1 displays the main clinical outcomes of the studied cases
and controls.
The study was approved by the ethics committee of the
UNIFESP. Written informed consent with approval of the ethics
committee was obtained from all patients prior to specimen
collection.
Tissue samples
During the arthroscopic procedures, tissue samples were
obtained from the AI, AS and P sites of the glenohumeral capsule
of each patient. Biopsy samples from the AI and AS sites were
obtained using the scope in the posterior portal and the basket
grasper in the anterior portal. The AI specimen was taken from
the most inferior region of the glenohumeral capsule next to the
inferior glenohumeral ligament, while the AS specimen was taken
in the direction of the anterior portal below the biceps tendon, in
the rotator interval area. The P specimen was taken in the
direction of the posterior portal during evaluation of the posterior
capsulolabral complex with the scope in the anterior portal and
the basket grasper in the posterior portal.
All tissue specimens were immediately immersed in RNAlater
solution (Qiagen, Germany) and stored at -20uC until RNA
extraction.
RNA extraction and cDNA synthesis
Total RNA was extracted using an RNeasy mini kit (Qiagen,
Germany) according to the manufacturer’s protocol. RNA
concentration and quality were determined using a Nanodrop
ND-1000 (Thermo Scientifc, USA) and the integrity of the RNA
was verified by gel electrophoresis on a 1% agarose gel. cDNA was
synthesized from 60–100 ng of RNA using a High-Capacity
cDNA Archive kit (Life Technologies, USA) according to the
manufacturer’s protocol.
RT-qPCR
To detect the range of expression of the six candidate reference
genes, reactions were performed in triplicate using TaqMan
inventoried Assays-on-Demand probes (Life Technologies, USA)
and the Applied Biosystems 7500 fast real-time PCR system.
To identify the best combination of reference genes, we also
quantified the mRNA expression of a target gene, COL1A1 using
the candidate reference genes for normalization. COL1A1 was
select as a target gene since it codified the a1 chain of human
procollagen type I, which is the most prominent protein of the
capsule [23]. In addition, upregulation of COL1A1, as well as
other collagen genes and their protein products, has been reported
in several joint injuries, including injured Achilles tendon[12,24],
anterior cruciate ligament[25,26,27] and rotator cuff tear[11,28].
For each sample, candidate reference and target genes were run
on the same plate to exclude technical variations. The 6 reference
genes and target gene are summarized in Table 2.
Table 1. Distribution of the clinical outcomes of shoulder instability patients and controls.
Variable Cases Controls
Age at surgery, years (mean 6 SD) 28.4266.21 30.35614.36
Gender (% of male) 92.3% 100%
Age of onset, years (mean 6 SD) 25.8367.38
Duration of condition, years (mean 6 SD) 2.763.03
Duration of condition (% of .1 year) 84.6%
Number of injuries (% of .1 dislocation episode) 69.2%
doi:10.1371/journal.pone.0105002.t001
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The expression of COL1A1 across the samples was calculated
using the equation 2(2DCt), in which [DCt (cycle threshold) =
target gene (collagen) Ct – geometric mean of reference genes Ct].
Analysis of reference gene expression stability
We categorized the tissue samples into the following 12 groups:
1) AI samples from cases (SI patients); 2) AS samples from cases; 3)
P samples from cases; 4) all tissue samples from cases; 5) AI
samples from controls; 6) AS samples from controls; 7) P samples
from controls; 8) all tissue samples from controls; 9) all AI samples;
10) all AS samples; 11) all P samples; and 12) all tissue samples.
For comparisons of candidate reference gene stability we used
NormFinder (http://www.mdl.dk/publicationsnormfinder.htm),
geNorm (http://medgen.ugent.be/,jvdesomp/genorm/http://
medgen.ugent.be/,jvdesomp/genorm/), BestKeeper1 (http://
www.gene-quantifcation.de/bestkeeper.html) and DataAssist
(http://www.lifetechnologies.com/us/en/home/technical-resources/
software-downloads/dataassist-software.html) software programs
according to the recommendations of the software guides.
NormFinder accounts for both intra- and inter-group variations
when evaluating the stability of each single reference gene and
assigns lower stability values to the genes that are most stably
expressed [29]. geNorm calculates the expression stability value
(M) for each gene based on the average pairwise expression ratio
between a particular gene and all other reference genes. The most
stably expressed gene yields the lowest M value, and then the two
most stable reference genes are determined by stepwise exclusion
of the least stable gene [15]. Bestkeeper was used to rank the 6
reference genes based on the standard deviation (SD) and
coefficient of variance (CV) expressed as a percentage of the cycle
threshold (Ct) level [30]. Lastly, DataAssist software provided a
metric to measure reference gene stability based on the geNorm
algorithm. In contrast to the other programs, DataAssist uses RQ
to calculate the stability value of individual candidate reference
genes.
GenEx software (http://genex.gene-quantifcation.info/) was
used to determine the optimal number of reference genes by
calculating the accumulated standard deviation (Acc.SD).
Results
Reference gene expression levels
The distribution of Ct values for each of the 6 candidate
reference genes is shown in Figure 1. These genes displayed a wide
range of expression levels. ACTB (mean Ct value 6 SD =
21.9162.327) followed by B2M (22.0862.436) presented the
highest expression levels. In contrast, TFRC (30.1162.125) and
Table 2. Summary of six reference genes and a target gene.
Gene symbol Name Accesion number Assay* Gene function
ACTB Beta-actin NM_001101.2 4352935E Cytoskeletal structural protein
B2M Beta-2-microglobulin NM_004048.2 4333766T Beta-chain of major histocompatibility complex class I
molecules
GAPDH Glyceraldehyde-3-phosphate dehydrogenase NM_002046.3 4352934E Oxidoreductase in glycolysis and gluconeogenesis
HPRT1 Hypoxanthine phosphoribosyl-transferase NM_000194.1 4333768T Purine synthesis in salvage pathway
TBP TATA box binding protein NM_003194.3 4333769T RNA polymerase II, transcription factor
TFRC Transferrin receptor (CD71) NM_003234.1 4333770T Cellular iron ion homeostasis
COL1A1 Collagen, type I, alpha 1 NM_000088.3 Hs00164004_m1 Extracellular matrix structural protein
*TaqMan probes were purchased as assays-on-demand products for gene expression (Life Technologies, USA).
doi:10.1371/journal.pone.0105002.t002
Figure 1. RT-qPCR detection of the expression levels of six reference genes. A lower cycle threshold value (Ct) indicates higher gene
expression. AI: antero-inferior region of the glenohumeral capsule; AS: antero-superior region of the glenohumeral capsule; P: posterior region of the
glenohumeral capsule.
doi:10.1371/journal.pone.0105002.g001
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Table 3. Ranking of the candidate single reference genes by each software package used.
NormFinder geNorm BestKeeper DataAssist
Stability value* Ranking M value* Ranking CV* Ranking Score* Ranking
AI samples of cases
0.193 HPRT1 0.419 TFRC 4.59 TFRC 0.782 GAPDH
0.350 ACTB 0.419 GAPDH 5.55 TBP 0.814 HPRT1
0.414 TFRC 0.488 HPRT1 5.57 GAPDH 0.8355 ACTB
0.435 GAPDH 0.503 ACTB 6.15 HPRT1 1.055 TBP
0.599 B2M 0.572 B2M 7.16 ACTB 1.131 TFRC
0.607 TBP 0.624 TBP 9.13 B2M 1.467 B2M
AS samples of cases
0.276 HPRT1 0.246 HPRT1 4.10 TFRC 0.768 GAPDH
0.293 GAPDH 0.246 B2M 4.43 TBP 0.823 HPRT1
0.463 TBP 0.444 GAPDH 4.72 HPRT1 0.869 ACTB
0.478 B2M 0.528 TBP 5.06 GAPDH 0.923 TFRC
0.486 TFRC 0.562 TFRC 5.18 ACTB 0.933 TBP
0.593 ACTB 0.611 ACTB 6.39 B2M 1.611 B2M
P samples of cases
0.179 HPRT1 0.337 B2M 4.41 TFRC 0.861 HPRT1
0.468 B2M 0.337 ACTB 5.39 HPRT1 0.987 TBP
0.520 ACTB 0.359 HPRT1 5.91 TBP 1.087 GAPDH
0.521 TBP 0.488 TBP 6.76 GAPDH 1.101 ACTB
0.610 TFRC 0.619 TFRC 7.70 ACTB 1.193 TFRC
0.933 GAPDH 0.752 GAPDH 7.88 B2M 1.462 B2M
All samples of cases
0.134 HPRT1 0.377 HPRT1 4.36 TFRC 0.836 HPRT1
0.224 B2M 0.377 B2M 5.36 TBP 0.913 GAPDH
0.246 TBP 0.523 ACTB 5.50 HPRT1 0.958 ACTB
0.254 ACTB 0.599 TBP 5.87 GAPDH 1.012 TBP
0.251 GAPDH 0.666 TFRC 6.83 ACTB 1.091 TFRC
0.275 TFRC 0.705 GAPDH 7.92 B2M 1.493 B2M
AI samples of controls
0.021 TBP 0.215 TBP 7.10 TBP 0.787 HPRT1
0.204 HPRT1 0.215 HPRT1 7.44 TFRC 0.798 ACTB
0.279 ACTB 0.321 ACTB 7.61 HPRT1 0.943 TBP
0.353 B2M 0.389 B2M 8.15 GAPDH 0.953 GAPDH
0.447 GAPDH 0.410 GAPDH 8.58 ACTB 1.110 TFRC
0.556 TFRC 0.471 TFRC 9.70 B2M 2.036 B2M
AS samples of controls
0.265 B2M 0.221 HPRT1 4.85 TFRC 1.063 HPRT1
0.358 HPRT1 0.221 B2M 4.79 TBP 1.144 GAPDH
0.402 TBP 0.364 TBP 6.13 HPRT1 1.180 ACTB
0.436 ACTB 0.470 GAPDH 6.92 GAPDH 1.199 TFRC
0.458 GAPDH 0.530 ACTB 7.23 B2M 1.249 TBP
0.491 TFRC 0.561 TFRC 7.94 ACTB 1.4613 B2M
P samples of controls
0.263 TBP 0.617 TFRC 3.85 HPRT1 1.301 TBP
0.303 TFRC 0.617 TBP 4.69 TFRC 1.351 HPRT1
0.574 HPRT1 0.685 HPRT1 4.73 TBP 1.582 ACTB
0.876 B2M 0.801 B2M 5.20 ACTB 1.639 GAPDH
0.946 ACTB 0.893 ACTB 5.66 GAPDH 1.702 TFRC
1.335 GAPDH 1.064 GAPDH 7.06 B2M 1.887 B2M
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TBP (29.9562.358) presented the lowest expression levels in
glenohumeral capsule samples.
Reference gene expression stability
Table 3 displays the stability value ranking of the single
candidate reference genes as determined by the different software
packages. In our analysis, all reference genes for all analysis groups
presented M values less than the geNorm threshold of 1.5 that is
recognized as stable.
For most of the analysis groups, the various software packages
suggested different single best reference genes, and all four
software packages generated different rankings of reference gene
stability for each analysis group.
Typically, gene expression studies compare transcript levels
between case (i.e., the injured tissue) and control samples. When
considering the AI samples, no single gene was repeatedly
identified as being the best reference gene by the various software
packages. In contrast, NormFinder, geNorm and DataAssist each
identified HPRT1 as the most stable gene in AS samples, and
NormFinder and BestKeeper both identified TFRC as the most
stable gene in P samples.
In some studies, researchers have investigated a possible
association between gene expression and clinical variables. In
Table 3. Cont.
NormFinder geNorm BestKeeper DataAssist
Stability value* Ranking M value* Ranking CV* Ranking Score* Ranking
All samples of controls
0.264 HPRT1 0.460 TBP 5.44 TBP 1.164 TBP
0.345 TFRC 0.460 B2M 5.62 TFRC 1.190 HPRT1
0.370 TBP 0.573 ACTB 5.77 HPRT1 1.244 ACTB
0.422 ACTB 0.637 HPRT1 7.25 ACTB 1.457 GAPDH
0.457 B2M 0.667 TFRC 7.27 GAPDH 1.599 TFRC
0.731 GAPDH 0.843 GAPDH 7.86 B2M 1.812 B2M
All AI samples
0.169 TBP 0.467 GAPDH 5.33 TFRC 0.833 HPRT1
0.207 HPRT1 0.467 ACTB 6.70 TBP 0.880 GAPDH
0.244 ACTB 0.541 HPRT1 6.99 HPRT1 0.852 ACTB
0.250 B2M 0.577 TBP 7.64 GAPDH 1.044 TBP
0.388 GAPDH 0.608 B2M 8.91 ACTB 1.161 TFRC
0.400 TFRC 0.631 TFRC 9.90 B2M 1.658 B2M
All AS samples
0.118 HPRT1 0.270 HPRT1 5.02 TBP 0.891 HPRT1
0.125 B2M 0.270 B2M 5.19 TFRC 0.932 GAPDH
0.143 GAPDH 0.460 GAPDH 5.93 HPRT1 0.998 ACTB
0.154 TBP 0.517 TBP 6.24 GAPDH 1.045 TBP
0.177 TFRC 0.555 TFRC 6.93 ACTB 1.046 TFRC
0.180 ACTB 0.598 ACTB 7.62 B2M 1.549 B2M
All P samples
0.183 TFRC 0.489 B2M 5.45 TFRC 1.000 HPRT1
0.191 HPRT1 0.489 ACTB 5.94 HPRT1 1.075 TBP
0.222 TBP 0.611 HPRT1 6.48 TBP 1.244 ACTB
0.294 B2M 0.633 TBP 6.59 GAPDH 1.27 GAPDH
0.328 ACTB 0.710 TFRC 8.54 B2M 1.322 TFRC
0.471 GAPDH 0.864 GAPDH 8.61 ACTB 1.546 B2M
All samples
0.056 HPRT1 0.494 HPRT1 5.31 TFRC 0.926 HPRT1
0.094 TBP 0.494 B2M 6.12 TBP 1.079 ACTB
0.098 TFRC 0.594 TBP 6.25 HPRT1 1.087 TBP
0.119 ACTB 0.626 ACTB 6.88 GAPDH 1.114 GAPDH
0.119 B2M 0.678 TFRC 8.13 ACTB 1.1927 TFRC
0.199 GAPDH 0.756 GAPDH 8.68 B2M 1.586 B2M
*A lower value indicates higher stability in gene expression. AI: antero-inferior region of the glenohumeral capsule; AS: antero-superior region of the glenohumeral
capsule; P: posterior region of the glenohumeral capsule.
doi:10.1371/journal.pone.0105002.t003
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the present study, HPRT1, followed by B2M was the most
suitable reference gene for the different tissue categories from
cases. For the tissue categories from controls, TBP and HPRT1
were the most stable reference genes.
When all 54 samples were considered, HPRT1 and B2M (M
value = 0.494) were identified as the most stably expressed
reference genes by geNorm, andHPRT1 was also identified as the
most stable reference gene by the NormFinder and DataAssist
software. Moreover, HPRT1 was the gene most frequently
identified as a suitable reference gene when considering all the
analysis groups.
Table 4 displays the best combinations of reference genes as
suggested by the 4 software packages. Overall, HPRT1 and B2M
were the most suitable reference genes, and this pair of genes was
the most frequently identified when evaluating all cases or all
samples, as well as when evaluating only AS samples. In contrast,
GAPDH and ACTB was the most frequently identified pair from
the analysis of AI samples; ACTB and B2M was the most
frequently identified pair from the analysis of P samples; and TBP
and B2M was the most frequently identified pair of reference
genes when all controls were evaluated simultaneously.
The 4 software packages only indicated up to 2 genes as the best
combination of reference genes. We used the GenEx software
package to determine if reliable normalization would require more
than 2 reference genes. In this analysis the optimal number of
reference genes is indicated by the lowest SD, and with the
exception of the analysis of P site samples from controls, the
Acc.SD of 2 reference genes did not differ more than 0.1 from the
observed metric when using more than 2 genes (Figure 2).
Effects of reference gene choice
To validate the selection of the appropriate reference genes for
normalization, an expression analysis was performed comparing
data from samples of patients with shoulder instability to controls
Table 4. Best pair of reference genes according to each software for each group of sample.
Samples Best pair of reference genes by software
NormFinder geNorm BestKeeper DataAssist
AI samples of cases HPRT1 + ACTB TFRC + GAPDH HPRT1 + B2M GAPDH + ACTB
AS samples of cases HPRT1 + GAPDH HPRT1 + B2M HPRT1 + B2M HPRT1 + GAPDH
P samples of cases HPRT1 + B2M ACTB + B2M HPRT1 + B2M HPRT1 + ACTB
All samples of cases HPRT1 + B2M HPRT1 + B2M HPRT1 + B2M HPRT1 + ACTB
AI samples of controls HPRT1 + TBP HPRT1 + TBP TBP + ACTB HPRT1 + ACTB
AS samples of controls HPRT1 + B2M HPRT1 + B2M HPRT1 + B2M TBP + TFRC
P samples of controls TBP + TFRC TBP + TFRC TBP + TFRC/TBP + B2M TBP + TFRC
All samples of controls HPRT1 + TFRC TBP + B2M TBP + B2M HPRT1 + TBP
All AI samples HPRT1 + TBP GAPDH + ACTB HPRT1 + B2M GAPDH + ACTB
All AS samples HPRT1 + B2M HPRT1 + B2M HPRT1 + B2M GAPDH + ACTB
All P samples HPRT1 + TFRC ACTB + B2M ACTB + B2M TBP + TFRC
All samples HPRT1 + TBP HPRT1 + B2M HPRT1 + B2M HPRT1 + ACTB
AI: antero-inferior region of the glenohumeral capsule; AS: antero-superior region of the glenohumeral capsule; P: posterior region of the glenohumeral capsule.
doi:10.1371/journal.pone.0105002.t004
Figure 2. Accumulated standard deviation for the 6 reference genes in glenohumeral capsule samples. Lower values of accumulated
standard deviation (Acc.SD) indicate the optimal number of reference gene as estimated by the GenEx software package. AI: antero-inferior region of
the glenohumeral capsule; AS: antero-superior region of the glenohumeral capsule; P: posterior region of the glenohumeral capsule.
doi:10.1371/journal.pone.0105002.g002
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for the three capsule sites. This analysis was performed using
COL1A1 as a target gene in all the analyses. As reference genes,
we used the most frequently identified pairs described above. We
also performed the COL1A1 expression analysis using 3 reference
genes (HPRT1 + B2M + ACTB) and 4 reference genes (HPRT1 +
B2M + ACTB + TBP).
Although the normalized expression quantities differed between
the various combinations of reference genes, the distributions of
COL1A1 expression in the studied samples were similar (Figure 3).
Moreover, COL1A1 expression was significantly increased in the
AS and P sites of the glenohumeral capsule of cases compared to
the controls using all the reference genes combinations described
above (p,0.05 for all analyses using the Mann-Whitney test;
Table 5). Regardless of the reference gene combination used,
COL1A1 expression in the capsule AI site did not differ between
cases and controls (p.0.05 using the Mann-Whitney test for all
analyses; Table 5).
Discussion
Our group recently began investigating the molecular alter-
ations involved in shoulder instability and other orthopedic lesions.
We hypothesized that misregulated expression of several genes
may have a role in the capsular deformation observed in SI
patients and that such molecular alterations may explain the high
rate of shoulder dislocation recurrence after the first episode of
traumatic dislocation. Additionally, an increased understanding of
gene expression modification in response to injury may aid in
determination of patient prognosis and in the development of new
treatment strategies.
RT-qPCR is one of the most commonly utilized approaches in
functional genomics research, and its use in gene expression
analysis may become routine. However, many authors do not
critically evaluate their RT-qPCR experiments, and as a result, the
experiments are improperly designed and difficult to repeat due to
insufficient data quality [31]. To minimize the influence of
differences between samples in the extraction of mRNA, reverse
transcription and PCR [17], is necessary to normalize target gene
expression by a known factor. Consequently, the use of suitable
reference genes with stable expression in the studied tissue (normal
and/or injured) is essential for effective data normalization and the
acquisition of accurate and meaningful biological data.
Reference genes have been described for RT-qPCR studies in
several diseases and tissues [20,21,22,32,33,34,35], and our group
recently identified the most stable reference genes in gastric
neoplastic and non-neoplastic samples, as well as in gastric cancer
cell lines [36]. To the best of our knowledge, no prior study has
sought to identify suitable reference genes for gene expression
analysis in the glenohumeral capsule.
In the present study, we used 4 software packages (NormFinder,
geNorm, BestKeeper, and DataAssist) to evaluate the stability of
reference gene expression. Each software package uses distinct
algorithms, and as a result, different results can be expected.
Therefore, it is important to use more than one software package
Figure 3. COL1A1 expression normalized by different combinations of candidate reference genes in glenohumeral capsule
specimens. AI: antero-inferior region of the glenohumeral capsule; AS: antero-superior region of the glenohumeral capsule; P: posterior region of
the glenohumeral capsule.
doi:10.1371/journal.pone.0105002.g003
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to identify the most suitable reference genes among a set of
candidates. Although the 4 software packages differed in their
rankings of reference gene stability as well as in the identity of the
most suitable pair, at least two programs produced results that
agreed for almost all the analyses. Our results demonstrate that the
use of 4 statistical tools aids the identification of the best reference
genes.
In the different groups of analyses, HPRT1 seems to be the
most suitable gene overall; however, it is increasingly clear that in
most situations a single reference gene is not sufficiently stable
[37]. When a larger number of reference genes is used, the SD of
the normalization factor (mean of reference gene expression) is
reduced and the random variation among the expression of tested
is partially cancelled.
Using the GenEx software, we observed that the Acc.SD of 2
reference genes differed no more than 0.1 from that observed in
most of the analysis groups when 3, 4, 5 or 6 reference genes were
used. Inclusion of additional reference genes increases the time
and money required for analysis; therefore, it is important to
consider the degree of improvement and overall noise contributed
by reference genes when deciding how many reference genes are
required. Considering that the reproducibility of real-time PCR
equipment is rarely less than 0.1 cycle (estimated as SD of
technical replicates), we believe that the use of more than two
reference genes does not significantly improve the data quality.
Only for the analysis of the control glenohumeral capsule P site
was the Acc.SD using 6 genes higher than 0.1 in comparison to the
use of 2 reference genes, meaning that the use of fewer reference
genes is also the most appropriate for this sample group.
Although different pairs of reference genes were determined to
be the most suitable for the various analysis groups, the
combination of HPRT1 and B2M was the most frequently
identified pair. Furthermore, our results demonstrated that
HPRT1 and B2M was the best gene pair for comparisons
requiring the use of a combination of reference genes for analysis
of samples of different portions of the glenohumeral capsule from
patients with and without SI.
To identify the best combination of reference genes, we
evaluated COL1A1 expression in samples from the AI, AS and
P sites of the glenohumeral capsules of cases and controls. To
normalize COL1A1 expression, we paired HPRT1 and B2M;
GAPDH and ACTB; ACTB and B2M and TBP and B2M.
Furthermore we normalized COL1A1 expression using the 3 and
4 most stable genes to evaluate the effects of increasing the number
of reference genes. Within the case and control groups, no obvious
differences in COL1A1 expression were observed when normal-
ized with different combinations of reference genes. Moreover,
statistical comparison revealed that COL1A1 expression differed
between the case and control samples from the AS and P capsule
portions independently of which reference gene combination was
used for normalization.
Therefore, our results show that combinations of 2 genes can be
used for the analysis of glenohumeral capsule samples and that it is
not necessary to use 3 or more reference genes. However, it should
be noted that all the reference genes presented an M value less
than the geNorm threshold of 1.5 recognized as stable under the
different experimental conditions tested.
Our study presented some limitations. First, we only included a
limited number of candidate reference genes, and it is likely that
some other genes may be also used as internal references for gene
expression studies in glenohumeral capsule samples from patients
with or without history of shoulder dislocation. Second, our results
only apply directly to glenohumeral capsule. It is unclear how well
our results could be extended to other joint capsules. Therefore,
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when new cohorts of tissue samples are used, we suggest
performing specific gene expression studies, in order to identify
the most stable reference genes to be used for normalization.
However, it is important to highlight that our results may be
relevant to the study of SI, as well as to the study of the normal
glenohumeral capsule.
Conclusions
In the present study, we evaluated the suitability of reference
genes using samples of glenohumeral capsules from individuals
with and without history of shoulder dislocation episodes.
Examining the different analysis groups, HPRT1 appears to be
the most suitable reference gene. We observed that 2 reference
genes, especiallyHPRT1 and B2M, might be used in combination
for accurate normalization of RT-qPCR data in studies of
molecular alterations in the glenohumeral capsule of SI patients.
The results of this work may benefit future studies of the
glenohumeral capsule that require more accurate gene expression
quantification in this tissue.
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